If cardiac patients benefit from statins, why not commonly prescribe them and follow up their use?

European Journal of Internal Medicine

Volumn 12, Issue 6, 2001, Pages 475-476

  Falger, P R J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BUDGET; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; DRUG USE; EDITORIAL; FOLLOW UP; HEALTH CARE COST; HEALTH PROGRAM; HEART REHABILITATION; HOSPITAL DISCHARGE; HUMAN; LIFESTYLE; MORBIDITY; MORTALITY; OUTPATIENT; PATIENT INFORMATION; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY OF LIFE; RECURRENT DISEASE; SECONDARY PREVENTION;

EID: 0035182261     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(01)00177-7     Document Type: Editorial

References (19)

1. AHA Dietary Guidelines. Revision 2000: A statement for health care professionals from the Nutrition Committee of the American Heart Association
2. Heart attack treatments
3. Psychosocial interventions for patients with coronary artery disease. A meta-analysis
4. A meta-analysis of psychoeducational programs for coronary heart disease patients
5. Risk factor modification through non-pharmacological interventions in patients with coronary heart disease
6. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease
7. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention. Role of physical exercise
8. Intensive lifestyle changes for reversal of coronary heart disease
9. Current concepts of the pathogenesis of the acute coronary syndromes
10. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
11. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
12. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
13. Use of the statins in patients after acute myocardial infarction
14. Coronary heart disease in the statin and aspirin era: Are results of clinical trials being put into practice?
15. In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease
16. Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of the European Society of Cardiology
17. Why patients do not attend cardiac rehabilitation: Role of intentions and illness beliefs
18. Persistence of use of lipid-lowering medications. A cross-national study